Newcastle Disease Virus Archive - IOZK

Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro

2021-07-25/in International Publications, Newcastle Disease Virus /von 2021-07-25 / Res Vet Sci 2021 Jul;139:159-165

Recombinant Newcastle disease virus immunotherapy drives oncolytic effects and durable systemic antitumor immunity

2021-06-17/in International Publications, Newcastle Disease Virus /von 2021-06-17 / Mol Cancer Ther 2021 Jun;

A bibliometric review of oncolytic virus research as a novel approach for cancer therapy

2021-05-12/in International Publications, Newcastle Disease Virus /von 2021-05-12 / Virol J 2021 May;18(1):98

MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

2021-04-21/in International Publications, Newcastle Disease Virus, NSCLC /von 2021-04-21 / Oncol Lett 2021 Jun;21(6):482

Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus

2021-03-30/in International Publications, Newcastle Disease Virus /von 2021-03-30 / Int J Med Sci 2021;18(11):2294-2302

The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma

2021-02-01/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2021-02-01 / Neurosurg Focus 2021 02;50(2):E8

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

2020-12-24/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)

Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice

2020-12-08/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2020-12-08 / PeerJ 2020;8:e9761

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy

2020-11-28/in International Publications, Newcastle Disease Virus /von 2020-11-28 / Cancers (Basel) 2020 Nov;12(12)

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials

2020-11-16/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-11-16 / Int J Mol Sci 2020 Nov;21(22)